StockNews.com Begins Coverage on Bellerophon Therapeutics (NASDAQ:BLPH)
StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Price Performance BLPH opened at $0.04 on Monday. The stock has a fifty day moving average of $0.27 and a 200-day moving […]
More Stories
2 Dead, 3 Injured in Shooting at Reno Casino; Suspect In Custody
By Tom Ozimek A man opened fire outside a Reno casino in Nevada on the morning of July 28, killing...
Top 10 Travel Management Software: Review in 2025
Anybody who has experience traveling for work knows that it is very difficult to maintain a record. Travel management software...
Zach Justice’s Bio: Age, Relationship, Movies, and Net Worth
Zach Justice is an American actor, content creator, and comedian, and is best known among fans for his funny skits...
Delta Co-Pilot Got Arrested Moments After Landing, Over Child Porn Charges
On 26 July 2025, Saturday, a Delta Airlines flight from Minneapolis to San Francisco landed around 9:35 p.m. after being...
‘Ransom Canyon’ Season 2 Release Date, Cast, & More
A new season of Ransom Canyon has been officially announced. This Texas-based romance show, starring Minka Kelly and Josh Duhamel,...
Nick Kurtz Hits 4 Home Runs: Athletics’ Rookie’s Historic Night By The Numbers
By FOX Sports Not 1. Not 2. Not 3. But, yes, FOUR freaking home runs were hit by Athletics rookie first baseman Nick...